Clinical trial

A Registry for People With T-cell Lymphoma

NCT05978141

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2023-07-27

PhaseN/A

Study timeline

Study start (actual)2023-07-27Date precision: day

Registry last updated2026-05-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

T-cell Lymphomaunresolved

NK-Cell Lymphomaunresolved

T-cell Prolymphocytic Leukemiaunresolved

T-cell Large Granular Lymphocytic Leukemiaunresolved

Chronic Lymphoproliferative Disorder of NK Cellsunresolved

Aggressive NK-cell Leukemiaunresolved

Systemic Epstein-Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhood (Disorder)unresolved

Systemic Epstein Barr Virus Positive T-Cell Lymphoproliferative Disease of Childhoodunresolved

Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Formunresolved

Hydroa Vacciniforme-Like Lymphoproliferative Disorderunresolved

Adult T-cell Leukemia/Lymphomaunresolved

Extranodal NK/T-cell Lymphoma, Nasal Typeunresolved

Enteropathy-associated T-cell Lymphomaunresolved

Monomorphic Epitheliotropic Intestinal T-Cell Lymphomaunresolved

Intestinal T-Cell Lymphoma, Not Otherwise Specifiedunresolved

Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tractunresolved

Hepatosplenic T-cell Lymphomaunresolved

Subcutaneous Panniculitis-Like T-Cell Lymphomaunresolved

Mycosis Fungoidesunresolved

Sezary Syndromeunresolved

Primary Cutaneous Anaplastic Large Cell Lymphomaunresolved

Primary Cutaneous T-cell Lymphomaunresolved

Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell Lymphomaunresolved

Primary Cutaneous Acral CD8-Positive T-Cell Lymphomaunresolved

Peripheral T-Cell Lymphoma, Not Otherwise Specifiedunresolved

Angioimmunoblastic T-cell Lymphomaunresolved

Follicular T-Cell Lymphomaunresolved

Nodal Peripheral T-Cell Lymphoma With TFH Phenotypeunresolved

Anaplastic Large Cell Lymphoma, ALK-Positiveunresolved

Anaplastic Large Cell Lymphoma, ALK-negativeunresolved

Breast Implant-Associated Anaplastic Large Cell Lymphomaunresolved

Interventions

Optional Blood Sample and Nail SampleOTHER

Sponsors & collaborators

Memorial Sloan Kettering Cancer Centerlead sponsor

Mapped research locations

New YorkNew York, United States2 BostonMassachusetts, United States2 PhiladelphiaPennsylvania, United States2 HoustonTexas, United States1 ChicagoIllinois, United States1 St LouisMissouri, United States1 AtlantaGeorgia, United States1 MiamiFlorida, United States1 San FranciscoCalifornia, United States1 San DiegoCalifornia, United States1 ColumbusOhio, United States1 TampaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05978141 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.